Bristol Myers Squibb (BMY) Stock Falls Amid Market Uptick: What Investors Need to Know

Yahoo FinanceOct 12 05:45

Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report

BenzingaOct 12 00:05

Perspective Falls After Data for Radiopharmaceutical in Skin Cancer

Seeking AlphaOct 11 22:10

Morgan Stanley Maintains Bristol-Myers Squibb(BMY.US) With Sell Rating, Maintains Target Price $37

Futu NewsOct 11 20:31 · Ratings

Kyverna, Cabaletta Started at Buys by UBS on CAR T Therapy Potential

Seeking AlphaOct 11 02:04

Correction to Old Drug Repurposed Article on Oct. 7 -- WSJ

WSJOct 10 02:09